Published in Br J Pharmacol on June 01, 1999
Functional disorders of the sympathetic nervous system in mice lacking the alpha 1B subunit (Cav 2.2) of N-type calcium channels. Proc Natl Acad Sci U S A (2001) 1.20
Tumour necrosis factor alpha activates nuclear factor kappaB signalling to reduce N-type voltage-gated Ca2+ current in postganglionic sympathetic neurons. J Physiol (2009) 0.85
Three types of neuronal calcium channel with different calcium agonist sensitivity. Nature (1985) 9.68
Calcium antagonism and calcium entry blockade. Pharmacol Rev (1986) 4.15
Dominant role of N-type Ca2+ channels in evoked release of norepinephrine from sympathetic neurons. Science (1988) 3.75
Structure and functional expression of alpha 1, alpha 2, and beta subunits of a novel human neuronal calcium channel subtype. Neuron (1992) 2.65
Blocking and isolation of a calcium channel from neurons in mammals and cephalopods utilizing a toxin fraction (FTX) from funnel-web spider poison. Proc Natl Acad Sci U S A (1989) 2.64
Distinctive pharmacology and kinetics of cloned neuronal Ca2+ channels and their possible counterparts in mammalian CNS neurons. Neuropharmacology (1993) 2.57
Calcium channel diversity and neurotransmitter release: the omega-conotoxins and omega-agatoxins. Annu Rev Biochem (1994) 2.53
A new Conus peptide ligand for mammalian presynaptic Ca2+ channels. Neuron (1992) 2.10
Purification and sequence of a presynaptic peptide toxin from Conus geographus venom. Biochemistry (1984) 1.96
Repeated measurements and multiple comparisons in cardiovascular research. Cardiovasc Res (1994) 1.84
Functional expression of a rapidly inactivating neuronal calcium channel. Nature (1993) 1.48
Analysis of competitive agonist-antagonist interactions by nonlinear regression. Trends Pharmacol Sci (1995) 1.48
The effect of omega conotoxin GVIA, a peptide modulator of the N-type voltage sensitive calcium channels, on motor responses produced by activation of efferent and sensory nerves in mammalian smooth muscle. Naunyn Schmiedebergs Arch Pharmacol (1988) 1.47
Effects of omega-conotoxin GVIA on autonomic neuroeffector transmission in various tissues. Br J Pharmacol (1990) 1.34
Action potentials must admit calcium to evoke transmitter release. Nature (1991) 1.19
Mechanism of presynaptic inhibition by neuropeptide Y at sympathetic nerve terminals. Nature (1993) 1.18
Refractory period fluid stimulation of right atria: a method for studying presynaptic receptors in cardiac autonomic transmission. J Pharmacol Methods (1981) 1.13
Block of calcium channels in rat neurons by synthetic omega-Aga-IVA. Neuropharmacology (1993) 1.07
Effects of N-, P- and Q-type neuronal calcium channel antagonists on mammalian peripheral neurotransmission. Br J Pharmacol (1996) 1.07
Multiple subtypes of voltage-gated calcium channel mediate transmitter release from parasympathetic neurons in the mouse bladder. J Neurosci (1996) 1.03
Role of N-, P- and Q-type voltage-gated calcium channels in transmitter release from sympathetic neurones in the mouse isolated vas deferens. Br J Pharmacol (1997) 0.99
Toxityping rat brain calcium channels with omega-toxins from spider and cone snail venoms. Biochemistry (1993) 0.97
Calcium channel subtypes for the sympathetic and parasympathetic nerves of guinea-pig atria. Br J Pharmacol (1995) 0.95
Effect of omega-agatoxin-IVA on autonomic neurotransmission. Eur J Pharmacol (1994) 0.94
Structure-function relationships of omega-conotoxin GVIA. Synthesis, structure, calcium channel binding, and functional assay of alanine-substituted analogues. J Biol Chem (1997) 0.91
Evidence of omega-conotoxin GV1A-sensitive Ca2+ channels in mammalian peripheral nerve terminals. Eur J Pharmacol (1988) 0.90
Selectivity of omega-conotoxin GVIA for n-type calcium channels in rat isolated small mesenteric arteries. Clin Exp Pharmacol Physiol (1996) 0.89
Neuropeptide Y1 receptors inhibit N-type calcium currents and reduce transient calcium increases in rat dentate granule cells. J Neurosci (1996) 0.88
A role for Q type Ca2+ channels in neurotransmission in the rat urinary bladder. Br J Pharmacol (1995) 0.88
Omega-conotoxin GVIA, the N-type calcium channel inhibitor, is sympatholytic but not vagolytic: consequences for hemodynamics and autonomic reflexes in conscious rabbits. J Cardiovasc Pharmacol (1990) 0.87
Differential effects of omega-conotoxin GVIA and MVIIC on nerve stimulation induced contractions of guinea-pig ileum and rat vas deferens. Eur J Pharmacol (1994) 0.86
Identification of calcium channels that control neurosecretion. Science (1994) 0.85
Hemodynamic and autonomic reflex effects of chronic N-type Ca2+ channel blockade with omega-conotoxin GVIA in conscious normotensive and hypertensive rabbits. J Cardiovasc Pharmacol (1995) 0.84
Response. Science (1994) 0.81
Effects of omega-toxins on noradrenergic neurotransmission in beating guinea pig atria. Eur J Pharmacol (1995) 0.80
Neuropeptide Y is a prejunctional inhibitor of vagal but not sympathetic inotropic responses in guinea-pig isolated left atria. Br J Pharmacol (1999) 0.78
Inhibition of Ca2+ channel currents in human neuroblastoma (SH-SY5Y) cells by neuropeptide Y and a novel cyclic neuropeptide Y analogue. Neuropharmacology (1995) 0.78
Inhibition of neuromuscular transmission in the myenteric plexus of guinea-pig ileum by omega-conotoxins GVIA, MVIIA, MVIIC and SVIB. Br J Pharmacol (1996) 0.78
Inhibition by omega-conotoxin GVIA of the chronotropic responses to sympathetic and parasympathetic nerve stimulation in the isolated, blood-perfused atrium of the dog. J Auton Pharmacol (1993) 0.78
Review: Ca2+ channel sub-types in peripheral efferent autonomic nerves. J Auton Pharmacol (1996) 0.78
Apparent vascular to cardiac sympatholytic selectivity of omega-conotoxin GVIA in the pithed rat. Eur J Pharmacol (1990) 0.77
Endothelium-dependent relaxation of coronary arteries by noradrenaline and serotonin. Nature (1983) 4.64
Enhanced total peripheral vascular responsiveness in hypertension accords with the amplifier hypothesis. J Hypertens (1999) 3.21
Release and properties of endothelium-derived relaxing factor (EDRF) from endothelial cells in culture. J Cell Physiol (1985) 2.24
Pharmacology of coronary artery bypass grafts. Ann Thorac Surg (1999) 1.87
Vasodilatation by acetylcholine is endothelium-dependent: a study by sonomicrometry in canine femoral artery in vivo. J Physiol (1983) 1.81
Analysis of anomalous pKb values for metiamide and atropine in the isolated stomach of the mouse. Br J Pharmacol (1979) 1.78
Alpha 2-adrenoceptors and endothelium-dependent relaxation in canine large arteries. Br J Pharmacol (1986) 1.69
Production of acid secretion in the mouse isolated stomach by electrical field stimulation [proceedings]. Br J Pharmacol (1978) 1.54
Analysis of competitive agonist-antagonist interactions by nonlinear regression. Trends Pharmacol Sci (1995) 1.48
Estimation of pKB values for histamine H2-receptor antagonists using an in vitro acid secretion assay. Br J Pharmacol (1980) 1.45
Developments of computer-based estimation of pA2 values and associated analysis. J Pharmacol Exp Ther (1978) 1.43
Inoprotection: the perioperative role of levosimendan. Anaesth Intensive Care (2007) 1.40
Evidence that acetylcholine-mediated hyperpolarization of the rat small mesenteric artery does not involve the K+ channel opened by cromakalim. Br J Pharmacol (1991) 1.36
Comparison of angiotensin converting enzyme inhibitors captopril and MK421-diacid in guinea pig atria. Eur J Pharmacol (1982) 1.35
Phentolamine and structurally related compounds selectively antagonize the vascular actions of the K+ channel opener, cromromakalim. Br J Pharmacol (1989) 1.31
The alpha adrenoceptors on endothelial cells. Fed Proc (1986) 1.21
The interaction of choline esters, vagal stimulation and H2-receptor blockade on acid secretion in vitro. Eur J Pharmacol (1982) 1.20
Comparison of contractile responses to 5-hydroxytryptamine and sumatriptan in human isolated coronary artery: synergy with the thromboxane A2-receptor agonist, U46619. Br J Pharmacol (1993) 1.18
Evidence against presynaptic alpha-adrenoreceptor modulation of cardiac sympathetic transmission. Nature (1980) 1.18
Vascular amplifier properties in renovascular hypertension in conscious rabbits. Hindquarter responses to constrictor and dilator stimuli. Hypertension (1987) 1.17
Characterization of responses to cromakalim and pinacidil in smooth and cardiac muscle by use of selective antagonists. Br J Pharmacol (1990) 1.16
Relaxation of large coronary artery by verapamil, D600, and nifedipine is constrictor selective: comparison with glyceryl trinitrate. J Cardiovasc Pharmacol (1983) 1.14
Refractory period fluid stimulation of right atria: a method for studying presynaptic receptors in cardiac autonomic transmission. J Pharmacol Methods (1981) 1.13
Comparative assay of histamine H2-receptor antagonists using the isolated mouse stomach [proceedings]. Br J Pharmacol (1978) 1.13
Relaxant effects of ATP and adenosine on canine large and small coronary arteries in vitro. Eur J Pharmacol (1987) 1.07
Effects of N-, P- and Q-type neuronal calcium channel antagonists on mammalian peripheral neurotransmission. Br J Pharmacol (1996) 1.07
Ergometrine contracts isolated canine coronary arteries by a serotonergic mechanism: no role for alpha adrenoceptors. J Pharmacol Exp Ther (1981) 1.04
Reactivity of the canine isolated internal mammary artery, saphenous vein, and coronary artery to constrictor and dilator substances: relevance to coronary bypass graft surgery. J Cardiovasc Pharmacol (1988) 0.99
Simultaneous determination of plasma noradrenaline and adrenaline kinetics. Responses to nitroprusside-induced hypotension and 2-deoxyglucose-induced glucopenia in the rabbit. Naunyn Schmiedebergs Arch Pharmacol (1990) 0.98
Reactivity of human isolated internal mammary artery to constrictor and dilator agents. Implications for treatment of internal mammary artery spasm. Circulation (1989) 0.97
Actions of serotonin antagonists on dog coronary artery. Eur J Pharmacol (1982) 0.96
Phentolamine--an unexpected agonist in the rabbit. Br J Pharmacol (1984) 0.96
5-HT receptors in the coronary circulation. Trends Pharmacol Sci (1989) 0.95
Glibenclamide is a competitive antagonist of the thromboxane A2 receptor in dog coronary artery in vitro. Br J Pharmacol (1990) 0.95
Pharmacological relaxation of the saphenous vein during harvesting for coronary artery bypass grafting. Ann Thorac Surg (1993) 0.94
Structure and the resistance amplifier in hypertension: reply to the dissenters. J Hypertens (2000) 0.94
Comparison of relaxation responses of vascular and non-vascular smooth muscle to endothelium-derived relaxing factor (EDRF), acidified sodium nitrite (NO) and sodium nitroprusside. Naunyn Schmiedebergs Arch Pharmacol (1990) 0.94
Omega-conotoxin GVIA is a potent inhibitor of sympathetic neurogenic responses in rat small mesenteric arteries. Br J Pharmacol (1990) 0.93
Chronotropic effects of angiotensin I, angiotensin II, bradykinin and vasopressin in guinea pig atria. Eur J Pharmacol (1982) 0.92
Effects of hypertension and hypercholesterolemia on vasodilatation in the rabbit. Hypertension (1986) 0.92
Role of auto-inhibitory feed-back in cardiac sympathetic transmission assessed by simultaneous measurements of changes in 3H-efflux and atrial rate in guinea-pig atrium. Br J Pharmacol (1984) 0.91
Structure-function relationships of omega-conotoxin GVIA. Synthesis, structure, calcium channel binding, and functional assay of alanine-substituted analogues. J Biol Chem (1997) 0.91
A device for measuring myocardial contractility. Med Biol Eng (1972) 0.90
Weak beta-adrenoceptor-mediated relaxation in the human internal mammary artery. J Thorac Cardiovasc Surg (1989) 0.89
Selectivity of omega-conotoxin GVIA for n-type calcium channels in rat isolated small mesenteric arteries. Clin Exp Pharmacol Physiol (1996) 0.89
Human vascular to cardiac tissue selectivity of L- and T-type calcium channel antagonists. Br J Pharmacol (1998) 0.88
Effects of alinidine (ST 567) on baroreceptor-heart rate reflexes and its interactions with clonidine on the baroreflex and on the sympathetic terminals of the isolated atrium. Eur J Pharmacol (1982) 0.88
Roles of key functional groups in omega-conotoxin GVIA synthesis, structure and functional assay of selected peptide analogues. Eur J Biochem (1999) 0.88
Effects of histamine bolus injections and continuous infusions on the H1- and H2-receptors in the hindlimb vessels of the rabbit. Clin Exp Pharmacol Physiol (1977) 0.87
Synthesis and characterization of a selective peptide antagonist of neuropeptide Y vascular postsynaptic receptors. Br J Pharmacol (1996) 0.87
Omega-conotoxin GVIA, the N-type calcium channel inhibitor, is sympatholytic but not vagolytic: consequences for hemodynamics and autonomic reflexes in conscious rabbits. J Cardiovasc Pharmacol (1990) 0.87
Central sympathoinhibition and peripheral neuronal uptake blockade after desipramine in rabbits. Am J Physiol (1991) 0.87
Role of disulfide bridges in the folding, structure and biological activity of omega-conotoxin GVIA. Biochim Biophys Acta (1999) 0.86
Estimation of non-autonomic and autonomic components of iliac bed vascular resistance in renal hypertensive rabbits. Cardiovasc Res (1975) 0.86
Pharmacological analysis of cannabinoid receptor activity in the rat vas deferens. Br J Pharmacol (2001) 0.85
Cardiovascular and autonomic effects of omega-conotoxins MVIIA and CVID in conscious rabbits and isolated tissue assays. Br J Pharmacol (2000) 0.85
Guanethidine-induced vasodilatation in the rabbit, mediated by endogenous histamine. Br J Pharmacol (1978) 0.85
Pharmacological characterisation of cannabinoid CB(1) receptors in the rat and mouse. Eur J Pharmacol (2000) 0.85
Cardiovascular action of verapamil in the dog with particular reference to myocardial contractility and atrioventricular conduction. Cardiovasc Res (1976) 0.85
Altered venous responses to vasoconstrictor agonists and nerve stimulation in human primary hypertension. J Hypertens (1990) 0.84
Hemodynamic and autonomic reflex effects of chronic N-type Ca2+ channel blockade with omega-conotoxin GVIA in conscious normotensive and hypertensive rabbits. J Cardiovasc Pharmacol (1995) 0.84
5-carboxamidotryptamine elicits 5-HT2 and 5-HT3 receptor-mediated cardiovascular responses in the conscious rabbit: evidence for 5-HT release from platelets. J Cardiovasc Pharmacol (1989) 0.83
The histamine-like effects of tolazoline and clonidine:: evidence against direct activity at histamine receptors. J Pharmacol Exp Ther (1981) 0.83
Changes in cardiac output and total peripheral resistance during development of renal hypertension in the rabbit: lack of confomity with the autoregulation theory. Circ Res (1976) 0.83
Verapamil: a selective antagonist of constrictor substances in dog coronary artery: implications for variant angina. Clin Exp Pharmacol Physiol Suppl (1982) 0.83
Diverse vascular responses to serotonin in the conscious rabbit: effects of serotonin antagonists on renal artery spasm. J Cardiovasc Pharmacol (1987) 0.83
Apparent frequency-dependent effect of clonidine on cardiac sympathetic transmission: the role of neuronal uptake. J Pharmacol Exp Ther (1982) 0.82
Amiloride analogues cause endothelium-dependent relaxation in the canine coronary artery in vitro: possible role of Na+/Ca2+ exchange. Br J Pharmacol (1988) 0.82
Endothelin is blood vessel selective: studies on a variety of human and dog vessels in vitro and on regional blood flow in the conscious rabbit. Clin Exp Pharmacol Physiol (1989) 0.82
Resistance control in hypertension. J Hypertens Suppl (1989) 0.81
Regional vascular resistance and heart rate responses mediated through H1- and H2-histamine receptors in the unanaesthetised rabbit. Eur J Pharmacol (1977) 0.81
Evidence against an action of mibefradil at N-type voltage-operated calcium channels. Naunyn Schmiedebergs Arch Pharmacol (2001) 0.81
Central nervous control of blood pressure in relation to antihypertensive drug treatment. Pharmacol Ther (1981) 0.80
Wall thickness to lumen diameter ratios of arteries from SHR and WKY: comparison of pressurised and wire-mounted preparations. J Vasc Res (1993) 0.80
Endogenous angiotensin II and bradykinin delay and attenuate the hypotension after N-type calcium channel blockade in conscious rabbits. J Cardiovasc Pharmacol (1998) 0.80
A functional study of the development of the cardiac sympathetic neuroeffector junction in the SHR. J Hypertens (1989) 0.79
Distribution of N-type Ca2+ channel binding sites in rabbit brain following central administration of omega-conotoxin GVIA. Eur J Pharmacol (1996) 0.79
An improved method for analysis of competitive agonist/antagonist interactions by non-linear regression. Ann N Y Acad Sci (1997) 0.79
Evidence that 5-HT2 receptors predominantly mediate the contraction of the rat basilar artery to 5-hydroxytryptamine. Eur J Pharmacol (1992) 0.79
Analysis of relaxation and repolarization mechanisms of nicorandil in rat mesenteric artery. Br J Pharmacol (1996) 0.79
Reversible inhibition of neuronal uptake by benextramine, an irreversible presynaptic alpha-adrenoceptor antagonist. Eur J Pharmacol (1984) 0.79
Acute and chronic inhibition of nitric oxide synthase in conscious rabbits: role of nitric oxide in the control of vascular tone. J Cardiovasc Pharmacol (1993) 0.78
No effect of atrial natriuretic factor on cardiac rate, force and transmitter release. Clin Exp Pharmacol Physiol (1986) 0.78
Vascular remodeling. Hypertension (1997) 0.78
Responses of dog large coronary arteries to constrictor and dilator substances: implications for the cause and treatment of variant angina pectoris. Am J Cardiol (1983) 0.78
Postural hypotension following N-type Ca2+ channel blockade is amplified in experimental hypertension. J Hypertens (2000) 0.78
Haemodynamic response to ketanserin in rabbits with Page hypertension: comparison with prazosin. J Hypertens (1983) 0.78
Neuropeptide Y is a prejunctional inhibitor of vagal but not sympathetic inotropic responses in guinea-pig isolated left atria. Br J Pharmacol (1999) 0.78
Separation of vasodilator and negative chronotropic actions in analogues of adenosine. Eur J Pharmacol (1972) 0.78
Intrarenal action of angiotensin II in restoring renal artery pressure after acute renal artery stenosis. Clin Exp Pharmacol Physiol (1979) 0.78
The cardiovascular effects of adrenaline, dobutamine and milrinone in rabbits using pressure-volume loops and guinea pig isolated atrial tissue. Anaesth Intensive Care (2007) 0.78
The effects of central administration of omega-conotoxin GVIA on cardiovascular parameters and autonomic reflexes in conscious rabbits. Clin Exp Pharmacol Physiol (1994) 0.78
Assessment of autonomic and non-autonomic components of resting hindlimb vascular resistance and reactivity to pressor substances in renal hypertensive rabbits. Clin Sci Mol Med Suppl (1976) 0.78
Disadvantages of cocaine as a neuronal uptake blocking agent: comparison with desipramine in guinea-pig right atrium. J Auton Pharmacol (1983) 0.78
Exogenous NPY modulation of cardiac autonomic reflexes and its pressor effect in the conscious rabbit. Br J Pharmacol (1998) 0.77
Prolonged cardiovascular effects of the N-type Ca2+ channel antagonist omega-conotoxin GVIA in conscious rabbits. J Cardiovasc Pharmacol (1997) 0.77
Role of NPY Y1 receptors in cardiovascular control in the conscious rabbit. J Cardiovasc Pharmacol (2000) 0.77
The salvage of rabbit ischaemic epigastric free flaps using the vasodilator calcitonin gene-related peptide. Br J Plast Surg (1990) 0.77
Clonidine and noradrenaline fail to inhibit vagal induced bradycardia. Evidence against prejunctional alpha-adrenoceptors on vagal varicosities in guinea pig right atria. Naunyn Schmiedebergs Arch Pharmacol (1983) 0.77